Business Information

• Snail Games Partners with Loric Games to Bring Echoes of Elysium to Market

  

  CULVER CITY,Calif.,Dec. 17,2024--Snail,Inc. (Nasdaq: SNAL) ("Snail Games" or the "Company"),a leading global independent developer and publisher of interactive digital entertainmen

  12-18

  Details

• WiMi Develops a New Design Solution for Simulating Quantum Computing Concepts Using FPGA

  

  BEIJING,Dec. 17,2024-- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"),a leading global Hologram Augmented Reality ("AR") Technology provider,today anno

  12-18

  Details

• Adrian Butler Elected to PRA Group Board of Directors

  

  The chief technology officer at Foot Locker,Butler brings more than 25 years of leadership experience across all areas of technology to the Board

  12-18

  Details

• U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

  

  STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn\'s disease (CD) and ulcerative coliti

  12-18

  Details

• China National Silk Museum Unveils "Silk and Silk Roads: From Hangzhou to Samarkand" Exhibition in Uzbekistan

  

  SAMARKAND,Uzbekistan,Dec. 12,2024--On December 6,2024,the China National Silk Museum launched the third thematic exhibition "Silk and Silk Roads: From Hangzhou to Samarkand" at the Samarkand

  12-18

  Details

• Luohu of Shenzhen: A Magnet for Global Investments

  

  SHENZHEN,China,Dec. 12,2024-- Saint-Gobain Group,a global leader in lightweight and sustainable construction solutions,reinvested in the Luohu district of Shenzhen this year.

  12-18

  Details

• Lichen China Limited Announces $2.70 Million Registered Direct Offering

  

  XIAMEN,China,Dec. 13,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it

  12-18

  Details

• Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024

  

  SUZHOU,China,Dec. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from a phase II clinical study on PD-L1/CTLA-4 bispecific antibody KN046 in combination with

  12-18

  Details

• WeBank Recognized on CNBC Best Banks Asia-Pacific 2024

  

  SHENZHEN,China,Dec. 13,2024-- Recognized for its resilience,adaptability,trustworthiness and reliability,WeBank is selected to the CNBC 2024 list of the Best Banks Asia-Pacific in China.

  12-18

  Details

• Global Aluminium Industry Greenhouse Gas Emissions Intensity Reduction Continues, With Total Emissions Below 2020 Peak

  

  Key Highlights: GHG emissions intensity reduced by 2.33% to 10.04 tonnes of CO2e per tonne of aluminium produced

  12-18

  Details